Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsRadiation InjuriesRadiation DosageRadiation, IonizingCisplatinDoxorubicinDose-Response Relationship, RadiationCombined Modality TherapyNeoplasmsCell Line, TumorRadiotherapyRadiation ToleranceEmployer Health CostsRadiotherapy DosageDrug Resistance, NeoplasmChemotherapy, AdjuvantEtoposideRadiationDrug Screening Assays, AntitumorAntineoplastic Agents, PhytogenicRadiation OncologyRadiation ProtectionRadiotherapy, ConformalCell SurvivalRadiotherapy, Intensity-ModulatedApoptosisPaclitaxelRadiation MonitoringTreatment OutcomeBreast NeoplasmsRadiotherapy, AdjuvantPrescription FeesDrug Delivery SystemsDose FractionationFluorouracilRadiation PneumonitisRadiotherapy Planning, Computer-AssistedBrachytherapyTumor Cells, CulturedRadiation-Sensitizing AgentsNeoplasm StagingNeoplasm Recurrence, LocalRadiometryDose-Response Relationship, DrugNeoplasms, Radiation-InducedDisease-Free SurvivalBrain NeoplasmsRadiation Injuries, ExperimentalSurvival AnalysisCyclophosphamideRadiosurgeryCell ProliferationTime FactorsGamma RaysSurvival RateLung NeoplasmsCranial IrradiationOvarian NeoplasmsPrognosisCosmic RadiationHead and Neck NeoplasmsRadiotherapy, Computer-AssistedGene Expression Regulation, NeoplasticFollow-Up StudiesNeoadjuvant TherapyAdenocarcinomaParticle AcceleratorsAntibiotics, AntineoplasticRadiotherapy, Image-GuidedCarcinoma, Squamous CellRadiation-Protective AgentsDrug Administration ScheduleRadiotherapy, High-EnergyRadiodermatitisVinblastineBackground RadiationChemoradiotherapyBleomycinDNA DamageAntimetabolites, AntineoplasticCarboplatinAntineoplastic Agents, AlkylatingMethotrexateProstatic NeoplasmsDacarbazineXenograft Model Antitumor AssaysMice, NudeOrgans at RiskUltraviolet RaysCarcinoma, Non-Small-Cell LungTomography, X-Ray ComputedTumor BurdenCobalt RadioisotopesClinical Trials as TopicRetrospective StudiesCamptothecinRadiation EffectsHodgkin DiseaseDeoxycytidine